AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Egetis Therapeutics

Major Shareholding Notification May 17, 2022

3152_iss_2022-05-17_1fe58e44-8021-4326-8bf7-f4b3733eeabc.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Egetis Therapeutics AB (publ)

Holder

RegulaPharm AB

Instrument

Instrument aktier
Before the transaction
Shares 9,846,730
Voting rights 9,846,730
Transaction
Reason for major shareholding notification New share issue
Date 17/05/2022
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 10,531,660
Directly held voting rights 10,531,660
Indirectly held voting rights 0
Percentage
Directly held shares 4.9 %
Directly held voting rights 4.9 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.9 % 10,531,660
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Cash settled - Physically settled
Total 4.9 % 10,531,660
Published 17/05/2022 21:53
Contact
Name Gudrun Hörnqvist
Phone 0709321440
Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.